Report Japan - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Nov 23, 2022

Japan - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Single report
Sent by email within 24h (Mon-Fri)

Japan: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Japan

In 2021, the Japanese human and animal blood market increased by 11% to $X for the first time since 2018, thus ending a two-year declining trend. In general, the total consumption indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +5.4% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption decreased by -11.5% against 2018 indices. Human and animal blood consumption peaked at $X in 2018; however, from 2019 to 2021, consumption stood at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Japan

In value terms, human and animal blood production rose rapidly to $X in 2021 estimated in export price. Overall, the total production indicated a strong increase from 2012 to 2021: its value increased at an average annual rate of +5.1% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production decreased by -15.3% against 2018 indices. The most prominent rate of growth was recorded in 2014 when the production volume increased by 34%. Over the period under review, production reached the maximum level at $X in 2018; however, from 2019 to 2021, production failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Japan

In 2021, exports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses from Japan dropped to X tons, with a decrease of -9% against the previous year. In general, exports continue to indicate a abrupt downturn. The most prominent rate of growth was recorded in 2016 with an increase of 16% against the previous year. The exports peaked at X tons in 2013; however, from 2014 to 2021, the exports failed to regain momentum.

In value terms, human and animal blood exports rose sharply to $X in 2021. Over the period under review, exports saw a perceptible decrease. The most prominent rate of growth was recorded in 2016 with an increase of 21% against the previous year. The exports peaked at $X in 2012; however, from 2013 to 2021, the exports remained at a lower figure.

Exports by Country

China (X tons), the United States (X tons) and Germany (X tons) were the main destinations of human and animal blood exports from Japan, together comprising 47% of total exports. These countries were followed by Taiwan (Chinese), South Korea, India, New Zealand, the Netherlands, Slovenia, Canada and Hong Kong SAR, which together accounted for a further 38%.

From 2012 to 2021, the biggest increases were in New Zealand (with a CAGR of +98.4%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), Germany ($X) and China ($X) constituted the largest markets for human and animal blood exported from Japan worldwide, together accounting for 56% of total exports. These countries were followed by New Zealand, South Korea, Taiwan (Chinese), India, Canada, the Netherlands, Hong Kong SAR and Slovenia, which together accounted for a further 21%.

Among the main countries of destination, New Zealand, with a CAGR of +90.0%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average human and animal blood export price amounted to $X per ton, with an increase of 24% against the previous year. Over the period under review, export price indicated buoyant growth from 2012 to 2021: its price increased at an average annual rate of +7.9% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood export price increased by +126.8% against 2013 indices. The most prominent rate of growth was recorded in 2014 when the average export price increased by 27%. Over the period under review, the average export prices hit record highs in 2021 and is likely to see gradual growth in the near future.

Prices varied noticeably country of destination: the country with the highest price was New Zealand ($X per ton), while the average price for exports to Slovenia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United States (+19.0%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Japan

In 2021, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were imported into Japan; picking up by 8.3% on the previous year's figure. In general, total imports indicated strong growth from 2012 to 2021: its volume increased at an average annual rate of +6.2% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +46.7% against 2019 indices. The most prominent rate of growth was recorded in 2020 when imports increased by 35%. Over the period under review, imports attained the peak figure in 2021 and are likely to continue growth in the near future.

In value terms, human and animal blood imports skyrocketed to $X in 2021. Overall, imports continue to indicate a strong expansion. The growth pace was the most rapid in 2019 with an increase of 79%. Imports peaked in 2021 and are likely to see gradual growth in the near future.

Imports by Country

In 2021, the United States (X tons) constituted the largest supplier of human and animal blood to Japan, accounting for a 43% share of total imports. Moreover, human and animal blood imports from the United States exceeded the figures recorded by the second-largest supplier, South Korea (X tons), fourfold. The third position in this ranking was taken by Denmark (X tons), with an 11% share.

From 2012 to 2021, the average annual rate of growth in terms of volume from the United States totaled +4.2%. The remaining supplying countries recorded the following average annual rates of imports growth: South Korea (+20.0% per year) and Denmark (+3.6% per year).

In value terms, Ireland ($X), the United States ($X) and Denmark ($X) constituted the largest human and animal blood suppliers to Japan, together comprising 81% of total imports.

Among the main suppliers, Ireland, with a CAGR of +66.4%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, picking up by 11% against the previous year. In general, the import price posted moderate growth. The pace of growth was the most pronounced in 2019 when the average import price increased by 81% against the previous year. Over the period under review, average import prices attained the peak figure in 2021 and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Ireland ($X per ton), while the price for Singapore ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Denmark (+10.1%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world?
+
The countries with the highest volumes of consumption in 2021 were the United States, China and India, together comprising 51% of global consumption. Canada, Japan, Russia, Brazil, France, Spain and the UK lagged somewhat behind, together accounting for a further 22%.
What are the largest producers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world?
+
The country with the largest volume of human and animal blood production was the United States, comprising approx. 40% of total volume. Moreover, human and animal blood production in the United States exceeded the figures recorded by the second-largest producer, China, twofold. The third position in this ranking was taken by India, with a 6.9% share.
What are the leading suppliers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to Japan?
+
In value terms, Ireland, the United States and Denmark were the largest human and animal blood suppliers to Japan, together accounting for 81% of total imports.
What are the leading importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses from Japan?
+
In value terms, the largest markets for human and animal blood exported from Japan were the United States, Germany and China, with a combined 56% share of total exports. These countries were followed by New Zealand, South Korea, Taiwan Chinese), India, Canada, the Netherlands, Hong Kong SAR and Slovenia, which together accounted for a further 21%.
What is the average export price for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Japan?
+
In 2021, the average human and animal blood export price amounted to $183,973 per ton, rising by 24% against the previous year.
What is the average import price for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Japan?
+
In 2021, the average human and animal blood import price amounted to $259,752 per ton, with an increase of 11% against the previous year.

This report provides an in-depth analysis of the market for human and animal blood in Japan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
• Japan

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in Japan
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption In 2007-2021
Table 5:
Imports, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Value Terms, By Country, 2012–2021
Table 7:
Import Prices, By Country Of Origin, 2012–2021
Table 8:
Exports, In Physical Terms, By Country, 2012–2021
Table 9:
Exports, In Value Terms, By Country, 2012–2021
Table 10:
Export Prices, By Country Of Destination, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2007-2021
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2007-2021
Figure 5:
Trade Balance, In Physical Terms, 2007-2021
Figure 6:
Trade Balance, In Value Terms, 2007-2021
Figure 7:
Per Capita Consumption, 2007-2021
Figure 8:
Market Forecast To 2030
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2012–2021
Figure 21:
Production, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, 2012–2021
Figure 23:
Imports, In Value Terms, 2012–2021
Figure 24:
Imports, In Physical Terms, By Country, 2021
Figure 25:
Imports, In Physical Terms, By Country, 2012–2021
Figure 26:
Imports, In Value Terms, By Country, 2012–2021
Figure 27:
Import Prices, By Country Of Origin, 2012–2021
Figure 28:
Exports, In Physical Terms, 2012–2021
Figure 29:
Exports, In Value Terms, 2012–2021
Figure 30:
Exports, In Physical Terms, By Country, 2021
Figure 31:
Exports, In Physical Terms, By Country, 2012–2021
Figure 32:
Exports, In Value Terms, By Country, 2012–2021
Figure 33:
Export Prices, By Country Of Destination, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET